-The Times of India NEW DELHI: No-detention provision in the Right to Education (RTE) Act is being touted as a big barrier towards quality education but a comprehensive report by the HRD ministry has revealed that 25 states already had no-detention policy even before the historical law came into force in 2009. It has also been revealed through analysis of District Information of System of Education data that learning ability in states...
More »SEARCH RESULT
Total Matching Records found : 973
Indian pharma's generic challenge-DG Shah
-The Business Standard USFDA's zero tolerance policy requires our drug firms to reorient not just processes but organisational cultures to serve that market credibly The following two quotes from the United States Food and Drug Administration (FDA) news releases may help put the Ranbaxy controversy in perspective. The first sums up what it is that drives the FDA and the second is typical of the challenge the pharmaceutical industry faces. (1) "The consent...
More »‘Government in the dark on status of 13 schemes’ -Nitin Sethi
-The Times of India NEW DELHI: If the dictum 'you can't manage what you can't measure' is true, then the government has an unsure grip over at least half the 13 flagship schemes worth nearly Rs 2 lakh crore annually, almost 80% of the total spend on central schemes. The government is unable to efficiently collate information to assess whether some of the 13 key flagship schemes are producing the results for...
More »UN report highlights benefits of school meal programmes in crisis settings
-The United Nations A United Nations report released today stresses the importance of providing meals for schoolchildren, particularly in times of crisis, and notes that this is still lacking in many developing countries. "School feeding assures that where quality education is available, children are able to take advantage of the opportunity to learn," said the Executive Director of the World Food Programme (WFP), Ertharin Cousin. "It's an investment that pays off in the...
More »A deception most foul-Narayan Lakshman
-The Hindu Ranbaxy's fraudulent practices may have jeopardised millions of lives in India, Africa and the U.S. Exactly two weeks ago, the pharmaceuticals industry was rocked by revelations that one of the world's largest generic drug manufacturers, Ranbaxy Laboratories, pleaded guilty to seven federal criminal charges stemming from its fraudulent production practices dating back to 2008, and agreed to pay U.S. regulators $500 million in fines. Much has since been said about Ranbaxy's...
More »
